Charles Schwab Investment Management Inc Axsome Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 337,246 shares of AXSM stock, worth $35.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
337,246
Previous 328,034
2.81%
Holding current value
$35.1 Million
Previous $27.8 Million
41.72%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$403 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$343 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$304 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$176 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$102 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.46B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...